- Filed
- Jan 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · Dec 22, 2023 | 34.21M sh |
| Stock Repurchased | Q2 2023 · Jan 31, 2023 | $0 |
| Stock Repurchased | Q2 2023 · Jan 31, 2022 | $92.5K |
| Cash And Equivalents | Q2 2023 · Jan 31, 2023 | $8.84K |
| Cash And Equivalents | Q2 2023 · Jul 31, 2022 | $32 |
| Current Liabilities | Q2 2023 · Jan 31, 2023 | $3.29M |
| Current Liabilities | Q2 2023 · Jul 31, 2022 | $3.22M |
| Total Liabilities | Q2 2023 · Jan 31, 2023 | $3.29M |
| Total Liabilities | Q2 2023 · Jul 31, 2022 | $3.22M |
| Current Assets | Q2 2023 · Jan 31, 2023 | $10.33K |
| Current Assets | Q2 2023 · Jul 31, 2022 | $40.71K |
| Total Assets | Q2 2023 · Jan 31, 2023 | $23.03K |
| Total Assets | Q2 2023 · Jul 31, 2022 | $206.9K |
| Sga Expense | Q2 2023 · Jan 31, 2023 | $58.03K |
| Sga Expense | Q2 2023 · Jan 31, 2023 | $65.82K |
| Sga Expense | Q2 2023 · Jan 31, 2022 | $52.7K |
| Sga Expense | Q2 2023 · Jan 31, 2022 | $115.16K |
| Operating Cash Flow | Q2 2023 · Jan 31, 2022 | −$296.96K |
| Stockholders Equity restated | Q2 2023 · Jan 31, 2022 | −$2.75M |
| Stockholders Equity restated | Q2 2023 · Oct 31, 2021 | −$2.44M |
| Stockholders Equity | Q2 2023 · Jul 31, 2021 | −$2.48M |
| Net Income | Q2 2023 · Jan 31, 2022 | −$752.46K |
| Net Income restated | Q2 2023 · Oct 31, 2021 | $0 |
| Operating Income | Q2 2023 · Jan 31, 2022 | −$868.08K |
| Operating Income | Q2 2023 · Jan 31, 2022 | −$1.09M |
| Gross Profit | Q2 2023 · Jan 31, 2022 | $0 |
| Gross Profit | Q2 2023 · Jan 31, 2022 | $0 |
| Cost Of Revenue | Q2 2023 · Jan 31, 2022 | $0 |
| Cost Of Revenue | Q2 2023 · Jan 31, 2022 | $0 |
| Revenue | Q2 2023 · Jan 31, 2022 | $0 |
| Revenue | Q2 2023 · Jan 31, 2022 | $0 |